Zobrazeno 1 - 10
of 27
pro vyhledávání: '"M L, Zubkin"'
Autor:
I. G. Kim, M. A. Lysenko, N. F. Frolova, L. Yu. Artyukhina, T. A. Buruleva, A. M. Nikitina, V. E. Vinogradov, E. V. Volodina, V. I. Chervinko, E. V. Kryukov, M. L. Zubkin
Publikováno v:
Russian Journal of Transplantology and Artificial Organs. 25:7-14
Therapy with neutralizing monoclonal antibodies (mAbs) is particularly relevant during COVID-19 outbreaks in patients at high risk of severe disease, including kidney transplant recipients (KTRs).Objective: to evaluate the efficacy and safety of neut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30a7c6147b1eddc1d0d2ce9c0d153ac2
https://doi.org/10.15825/1995-1191-2023-1-7-14
https://doi.org/10.15825/1995-1191-2023-1-7-14
Autor:
V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 27, Iss 6, Pp 52-62 (2018)
Introduction. The options of antiviral therapy (AVT) in the stages of severe liver fibrosis and cirrhosis (LC) as well as in the patients with comorbidities for the long time were limited to the standard therapy by pegilated interferon (peg-IFN) in c
Externí odkaz:
https://doaj.org/article/648fb9a0265848459515bd7b7ee40f58
Publikováno v:
Терапевтический архив, Vol 88, Iss 11, Pp 138-148 (2016)
Hepatitis C virus (HCV) infection results in not only chronic hepatitis and subsequent complications as liver cirrhosis and hepatocellular carcinoma, but also in a significant number of other diseases, the so-called extrahepatic manifestations of chr
Externí odkaz:
https://doaj.org/article/25fad464c5914cf29bd68f79ad0e6519
Publikováno v:
Терапевтический архив, Vol 88, Iss 10, Pp 105-113 (2016)
Hepatitis C virus (HCV) infection results in not only chronic hepatitis and subsequent complications as liver cirrhosis and hepatocellular carcinoma, but also in a significant number of other diseases, the so-called extrahepatic manifestations of chr
Externí odkaz:
https://doaj.org/article/eb087f8fca6448388ccd45a576c2e86b
Autor:
N. A. Tomilina, V. A. Berdinsky, E. V. Volodina, T. A. Buruleva, E. S. Ivanova, I. V. Ostrovskaya, Vladimir Vinogradov, M. L. Zubkin, D. A. Titov, Irina Kim, M. E. Maltseva, Artyukhina, L. Yu, Frolova, N. F., A. V. Frolov, I. A. Skryabina
Publikováno v:
Nephrology and Dialysis. 23:174-184
The study aimed to assess the clinical course and risk factors for adverse outcomes, as well as the treatment options for COVID-19 in renal transplant recipient (RTR). Patients and methods: a retrospective study included 279 RTRs (M 60.9%, age 49.9±
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c6f49f7bc446f11b9151de527ff472a
https://doi.org/10.28996/2618-9801-2021-2-174-184
https://doi.org/10.28996/2618-9801-2021-2-174-184
Autor:
N.F. Frolova, E.V. Kryukov, K. E. Loss, N. A. Tomilina, V.I. Chervinko, A. I. Ushakova, S. S. Usatiuk, E.V. Volodina, M L Zubkin, Artyukhina, L. Yu, Iskhakov, R. T., V. V. Varyasin, D. O. Sinyavkin, I. G. Kim, E. N. Diakova
Publikováno v:
Infectious diseases: News, Opinions, Training. 10:14-23
Objective. Evaluation of clinical observation, the course, the risk factors, and treatment options for SARS-CoV-2 infection in hemodialysis patients with end-stage chronic kidney disease. Material and methods. The retrospective, single-center, uncont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c5b3855ea0bd44a3db54965eeedae8d
https://doi.org/10.33029/2305-3496-2021-10-1-14-23
https://doi.org/10.33029/2305-3496-2021-10-1-14-23
Autor:
G. V. Volgina, I. G. Kim, E. N. Djakova, N. A. Tomilina, A. V. Frolov, K. E. Loss, M. L. Zubkin, Artyukhina, L. Yu, Buruleva, T. A., N. F. Frolova
Publikováno v:
Nephrology and Dialysis. 23:147-159
COVID-19 is a severe acute respiratory disease caused by the SARS-CoV-2 virus. Although COVID-19 is characterized mainly by diffuse alveolar damage and acute respiratory failure, in some cases COVID-19 may acquire extra-respiratory features, includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2af90108b741014c82078cbe96144775
https://doi.org/10.28996/2618-9801-2021-2-147-159
https://doi.org/10.28996/2618-9801-2021-2-147-159
Autor:
M. L. Zubkin, T. A. Semenenko, E. P. Selkova, F. K. Kokoeva, V. I. Chervinko, E. M. Balakirev, V. A. Aleshkin
Publikováno v:
Vestnik Transplantologii i Iskusstvennyh Organov, Vol 14, Iss 4, Pp 103-114 (2012)
Hepatitis E is enterically transmitted infection and is the cause of outbreaks and sporadic cases. Disease was originally registered only in the developing subtropical and tropical countries and has been connected with I or II genotypes of hepatitis
Externí odkaz:
https://doaj.org/article/e62088561f034ebdb7ce83d09275e206
Autor:
M. L. Zubkin, Ye. P. Sel'kova, F. K. Kokoyeva, T. A. Semenenko, V. I. Chervinko, A. N. Kolomoyets, E. M. Balakirev, A. V. Frolov, T. P. Nekrasova
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 21, Iss 5, Pp 52-57 (2011)
Aim of investigation. To estimate efficacy and safety of entecavir (ETV) in chronic hepatitis B (CHB) at renal graft recipients (RGR).Material and methods. Four RGR with CHB on in mean 71,5±36,9 month after kidney transplantation received treatment
Externí odkaz:
https://doaj.org/article/faa44d41adc047db808a91ee910064a4
Autor:
V.V. Rameev, E.A. Stepanova, D.V. Kalinin, O.M. Ruseikina, M L Zubkin, O.V. Logunov, E.S. Stolyarevich, V.I. Chervinko, N.F. Frolova, S G Radenska-Lopovok
Publikováno v:
Nephrology and Dialysis. 19:315-321
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f50397ea41f8258242f3202312fb93a
https://doi.org/10.28996/1680-4422-2017-2-315-321
https://doi.org/10.28996/1680-4422-2017-2-315-321